FDA's Medication Errors Director To Join The Private Sector
This article was originally published in The Pink Sheet Daily
Executive Summary
Jerry Phillips will join the Drug Safety Institute after 30 years in the Public Health Service. He will continue his work assessing the safety of drug names; a pending FDA guidance will likely prompt companies to increase the volume of nomenclature studies they conduct.